30 years of obesity research and over 100 years of medical breakthroughs
The backstory: CVS Caremark, the nations largest pharmacy benefit manager, stopped covering Zepbound on July 1, 2025, after reaching a deal with Novo Nordisk, the maker of rival GLP-1 drug Wegovy
This is not just a statistical drop-off
Adv Prostaglandin Thromboxane Leukot Res 17A:474478 Stitham J, Stojanovic A, Ross LA, Blount AC Jr, Hwa J (2004) Clusters of transmembrane residues are critical for human prostacyclin receptor activation
Type 2 diabetes affects millions of people worldwide and is characterized by high levels of sugar (glucose) in the blood
Unexpected weight loss: Losing weight is a known effect of tirzepatide, but the weight loss should be slow and steady